EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization

Steven Droho, Amrita Rajesh, Carla M Cuda, Harris Perlman, Jeremy A Lavine

JCI Insight · 2023

DOI: 10.1172/jci.insight.168142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2023. Verfasst von Steven Droho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Wet Macular Degeneration. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIAMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with neovascular AMD (nAMD) suffer vision loss from destructive angiogenesis, termed choroidal neovascularization (CNV). Macrophages are found in CNV lesions from patients with nAMD. Additionally, Ccr2 –/– mice, which lack classical monocyte–derived macrophages, show reduced CNV size. However, macrophages are highly diverse cells that can perform multiple functions. We performed single-cell RNA-Seq on immune cells from WT and Ccr2 –/– eyes to uncover macrophage heterogeneity during the laser-induced CNV mouse model of nAMD. We identified 12 macrophage clusters, including Spp1 + macrophages. Spp1 + macrophages were enriched from WT lasered eyes and expressed a proangiogenic transcriptome via multiple pathways, including vascular endothelial growth factor signaling, endothelial cell sprouting, cytokine signaling, and fibrosis. Additionally, Spp1 + macrophages expressed the marker CD11c, and CD11c + macrophages were increased by laser and present in CNV lesions. Finally, CD11c + macrophage depletion reduced CNV size by 40%. These findings broaden our understanding of ocular macrophage heterogeneity and implicate CD11c + macrophages as potential therapeutic targets for treatment-resistant patients with nAMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal NeovascularizationWet Macular DegenerationAnimalsMiceAngiogenesis InhibitorsMacrophagesVascular Endothelial Growth Factor AVisual AcuityCD11c Antigen

Stichwörter der Autor:innen

InflammationMacrophagesOphthalmologyRetinopathy

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ACD11c Antigen

Autor:innen und Institutionen

  • Department of Ophthalmology and.
  • Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Förderung

  • NIA NIH HHS
  • NIAMS NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • NEI NIH HHS
  • NHLBI NIH HHS
  • Lupus Research Alliance
  • Rheumatology Research Foundation

Zitieren

APA

Droho, S., Rajesh, A., Cuda, C. M., Perlman, H., & Lavine, J. A. (2023). CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization. JCI Insight. https://doi.org/10.1172/jci.insight.168142

Vancouver

Droho S, Rajesh A, Cuda CM, Perlman H, Lavine JA. CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization. JCI Insight. 2023. doi:10.1172/jci.insight.168142

BibTeX
@article{Droho2023,
  author = {Droho, Steven and Rajesh, Amrita and Cuda, Carla M and Perlman, Harris and Lavine, Jeremy A},
  title = {CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization},
  journal = {JCI Insight},
  year = {2023},
  doi = {10.1172/jci.insight.168142}
}
Kostenlos starten →